Regeneron has become the first company to get US approval for a gene therapy for congenital hearing loss, after the FDA gave ...

Just days after President Trump signed an executive order to broaden access to psychedelic medicines, the United States ...

There has been a major data security lapse at the UK Biobank, with "de-identified" data from its 500,000 volunteers listed ...

Berkeley, California biotech Ray Therapeutics, a specialist in the development of optogenetic therapies for eye disorders, ...

Armed with new phase 3 data, Novo Nordisk has said it will file for approval of oral formulations of its GLP-1 agonist ...

Roche has started its financial reporting for 2026 with a 5% fall in first-quarter revenues, hit by the appreciation of the ...